The 9678.HK stock (Unisound AI Technology Co Ltd., HKSE) trades at HKD 316.40 in pre-market on 28 Feb 2026, following a mixed one‑month swing and heavy intraday range. Volume is 470,240 shares versus a 50‑day average of 556,241, signalling continued market interest. Investors watching AI names should weigh Unisound’s large language model positioning against a negative EPS of -7.91 and a trailing PE of -41.31. This note breaks down valuation, technicals, Meyka AI grading, and realistic price targets for short and medium term setups.

9678.HK stock: market snapshot and recent moves

Unisound AI (9678.HK) opened at HKD 311.80 and hit a day high of HKD 317.40 with a day low of HKD 297.40. The share price sits well below the 200‑day average of HKD 497.34 but close to the 50‑day average of HKD 335.53. Daily liquidity is moderate with 470,240 shares traded, relative volume 2.46, suggesting above‑average turnover in this pre‑market session.

Year range is wide at HKD 198.00 to HKD 879.00, reflecting post‑IPO volatility since the June 2025 listing. Short‑term returns show a +48.68% move over 1 month and -48.21% over 3 months, underlining rapid sentiment shifts common in AI stocks.

Drivers: product, UniBrain adoption and sector context

Unisound’s UniBrain platform targets smart life and smart healthcare applications, a key reason institutional interest remains. Recent developer partnerships and product pilots are the growth narrative investors follow for revenue scaling and margin improvement.

At the same time, the Technology sector in Hong Kong has outperformed over 12 months (sector 1Y performance +34.95%) and sets a high bar for profitability. Unisound faces competition from larger cloud and AI players, so execution on commercial contracts will determine whether the stock follows sector gains or lags on valuation concerns.

Valuation and fundamentals: where 9678.HK stands

Unisound reports EPS -7.91 and a negative PE of -41.31, reflecting current losses. Market capitalisation is HKD 23,190,037,806.00 with 70,960,948 shares outstanding. The company’s negative profitability contrasts with the Technology sector average PE of 35.31, highlighting a valuation gap for investors to price in future margin recovery.

Analyst coverage is thin since the 2025 IPO, so multiples are driven by forward growth expectations. We use three price target scenarios below to translate execution outcomes into valuations: base HKD 380.00, bull HKD 520.00, bear HKD 240.00.

Technical setup and trading signals for 9678.HK stock

Momentum indicators are mixed. RSI is 47.28, near neutral. MACD is -5.53 with a signal line at -8.43 and a histogram of 2.90, suggesting a recent bullish crossover. Bollinger Bands middle band sits at HKD 327.41 with an upper band of HKD 402.68, placing the current price below the 50‑day mean but above the lower band.

Volatility is high: ATR HKD 40.50 and OBV 11,202,496 indicate active flows. Short‑term support cluster: HKD 297.40 then HKD 240.00. Key resistance: HKD 335.53 (50‑day) then HKD 497.34 (200‑day). Traders should watch volume confirmation for breakouts.

Meyka AI grade and model forecasts for 9678.HK

Meyka AI rates 9678.HK with a score of 63.89 out of 100 — Grade B — Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and not financial advice.

Meyka AI’s forecast model projects a monthly price of HKD 533.54 (implied +68.53% vs current HKD 316.40) and a quarterly price of HKD 82.17 (implied -73.99%). Forecasts are model‑based projections and not guarantees. Investors should consider both scenarios when sizing positions.

Risks and catalysts shaping 9678.HK outlook

Key risks: continued operating losses, near‑term margin pressure, execution delays for UniBrain contracts, regulatory shifts in China tech policy, and high stock volatility given the wide 52‑week range.

Potential catalysts: large enterprise wins, regulatory clarity, faster product monetisation in healthcare, and positive quarterly revenue beats. Positive signals from any catalyst could push the stock toward the bull target of HKD 520.00.

Final Thoughts

We view the 9678.HK stock as a growth‑stage AI infrastructure play with a binary return profile. At HKD 316.40 in pre‑market on 28 Feb 2026 the market prices strong AI potential but not guaranteed profitability. Meyka AI’s model gives a monthly projection of HKD 533.54 (implied +68.53%), while a contrasting quarterly projection of HKD 82.17 highlights downside risk in low‑execution scenarios. Our base case target is HKD 380.00 (implied +20.13%). Investors should treat positions sizeably, monitor contract announcements and quarterly revenue, and use stop levels near HKD 240.00. For more data and live monitoring, see Unisound’s site and the Meyka stock page for 9678.HK updates

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.